Retatrutide 40mg is a next-generation triple-agonist research peptide that simultaneously targets GLP-1, GIP, and glucagon receptors. Studied for its role in metabolic regulation, appetite signaling, and energy expenditure, it represents one of the most advanced high-dose compounds in this class. Supplied as a lyophilized powder for research use only.